Ac-Aib-Pro-Aib-Ala-Aib-Aib-Gln-Aib-Leu-Aib-Gly-Aib-Aib-Pro-Val-Aib-Iva-Gln-Gln-Leu-ol
| Internal ID | 75320acb-0f2d-41cf-8c76-ff698566db9a |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | (2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-1-[2-[[2-[[2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[2-[[2-[[(2S)-2-[[2-[[(2S)-1-(2-acetamido-2-methylpropanoyl)pyrrolidine-2-carbonyl]amino]-2-methylpropanoyl]amino]propanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-2-methylpropanoyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]acetyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]-2-methylbutanoyl]amino]-5-amino-5-oxopentanoyl]amino]-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]pentanediamide |
| SMILES (Canonical) | CCC(C)(C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)CO)NC(=O)C(C)(C)NC(=O)C(C(C)C)NC(=O)C1CCCN1C(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)CNC(=O)C(C)(C)NC(=O)C(CC(C)C)NC(=O)C(C)(C)NC(=O)C(CCC(=O)N)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C2CCCN2C(=O)C(C)(C)NC(=O)C |
| SMILES (Isomeric) | CC[C@@](C)(C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)CO)NC(=O)C(C)(C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1C(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)CNC(=O)C(C)(C)NC(=O)[C@H](CC(C)C)NC(=O)C(C)(C)NC(=O)[C@H](CCC(=O)N)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)[C@H](C)NC(=O)C(C)(C)NC(=O)[C@@H]2CCCN2C(=O)C(C)(C)NC(=O)C |
| InChI | InChI=1S/C90H155N23O24/c1-29-90(28,78(135)99-53(35-38-59(92)117)65(122)97-52(34-37-58(91)116)64(121)96-51(45-114)42-46(2)3)111-77(134)87(22,23)108-70(127)62(48(6)7)101-68(125)56-32-30-40-112(56)80(137)89(26,27)110-75(132)85(18,19)103-61(119)44-94-71(128)81(10,11)106-67(124)55(43-47(4)5)100-73(130)83(14,15)105-66(123)54(36-39-60(93)118)98-74(131)84(16,17)109-76(133)86(20,21)104-63(120)49(8)95-72(129)82(12,13)107-69(126)57-33-31-41-113(57)79(136)88(24,25)102-50(9)115/h46-49,51-57,62,114H,29-45H2,1-28H3,(H2,91,116)(H2,92,117)(H2,93,118)(H,94,128)(H,95,129)(H,96,121)(H,97,122)(H,98,131)(H,99,135)(H,100,130)(H,101,125)(H,102,115)(H,103,119)(H,104,120)(H,105,123)(H,106,124)(H,107,126)(H,108,127)(H,109,133)(H,110,132)(H,111,134)/t49-,51-,52-,53-,54-,55-,56-,57-,62-,90-/m0/s1 |
| InChI Key | YTJLXEDZXRLDME-AIKBURLSSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C90H155N23O24 |
| Molecular Weight | 1943.30 g/mol |
| Exact Mass | 1942.16153290 g/mol |
| Topological Polar Surface Area (TPSA) | 714.00 Ų |
| XlogP | -2.80 |
| Atomic LogP (AlogP) | -4.61 |
| H-Bond Acceptor | 24 |
| H-Bond Donor | 22 |
| Rotatable Bonds | 53 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7688 | 76.88% |
| Caco-2 | - | 0.8579 | 85.79% |
| Blood Brain Barrier | - | 0.5750 | 57.50% |
| Human oral bioavailability | - | 0.5857 | 58.57% |
| Subcellular localzation | Lysosomes | 0.6661 | 66.61% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8449 | 84.49% |
| OATP1B3 inhibitior | + | 0.9386 | 93.86% |
| MATE1 inhibitior | - | 0.9412 | 94.12% |
| OCT2 inhibitior | - | 0.9500 | 95.00% |
| BSEP inhibitior | + | 0.9587 | 95.87% |
| P-glycoprotein inhibitior | + | 0.7420 | 74.20% |
| P-glycoprotein substrate | + | 0.8657 | 86.57% |
| CYP3A4 substrate | + | 0.7384 | 73.84% |
| CYP2C9 substrate | - | 0.7929 | 79.29% |
| CYP2D6 substrate | - | 0.8494 | 84.94% |
| CYP3A4 inhibition | - | 0.5261 | 52.61% |
| CYP2C9 inhibition | - | 0.8902 | 89.02% |
| CYP2C19 inhibition | - | 0.7642 | 76.42% |
| CYP2D6 inhibition | - | 0.8894 | 88.94% |
| CYP1A2 inhibition | - | 0.8981 | 89.81% |
| CYP2C8 inhibition | + | 0.6869 | 68.69% |
| CYP inhibitory promiscuity | - | 0.9754 | 97.54% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.7300 | 73.00% |
| Carcinogenicity (trinary) | Non-required | 0.6000 | 60.00% |
| Eye corrosion | - | 0.9799 | 97.99% |
| Eye irritation | - | 0.8954 | 89.54% |
| Skin irritation | - | 0.7837 | 78.37% |
| Skin corrosion | - | 0.8734 | 87.34% |
| Ames mutagenesis | - | 0.6700 | 67.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6989 | 69.89% |
| Micronuclear | + | 0.5900 | 59.00% |
| Hepatotoxicity | + | 0.5657 | 56.57% |
| skin sensitisation | - | 0.8785 | 87.85% |
| Respiratory toxicity | + | 0.7556 | 75.56% |
| Reproductive toxicity | + | 0.8111 | 81.11% |
| Mitochondrial toxicity | + | 0.7000 | 70.00% |
| Nephrotoxicity | - | 0.6393 | 63.93% |
| Acute Oral Toxicity (c) | III | 0.6627 | 66.27% |
| Estrogen receptor binding | - | 0.5683 | 56.83% |
| Androgen receptor binding | + | 0.7650 | 76.50% |
| Thyroid receptor binding | + | 0.7668 | 76.68% |
| Glucocorticoid receptor binding | + | 0.8305 | 83.05% |
| Aromatase binding | + | 0.8095 | 80.95% |
| PPAR gamma | + | 0.7977 | 79.77% |
| Honey bee toxicity | - | 0.7362 | 73.62% |
| Biodegradation | - | 0.8750 | 87.50% |
| Crustacea aquatic toxicity | + | 0.5224 | 52.24% |
| Fish aquatic toxicity | - | 0.6701 | 67.01% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.77% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.53% | 96.61% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 99.48% | 94.45% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.80% | 98.33% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 98.72% | 98.94% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 98.35% | 95.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 98.02% | 93.56% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.91% | 96.09% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 97.54% | 92.38% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 97.45% | 99.77% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 97.25% | 87.16% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 97.05% | 97.25% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 96.36% | 96.47% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 96.30% | 98.24% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.89% | 97.09% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 95.82% | 92.12% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 95.77% | 98.05% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 95.62% | 94.66% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 95.49% | 96.31% |
| CHEMBL236 | P41143 | Delta opioid receptor | 95.46% | 99.35% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 95.38% | 91.19% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 95.28% | 100.00% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 94.76% | 95.71% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 94.75% | 98.10% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 94.69% | 96.67% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 94.13% | 83.14% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 94.01% | 100.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 93.70% | 97.14% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 93.63% | 100.00% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 93.61% | 95.38% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 93.29% | 98.89% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 93.26% | 94.00% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 93.12% | 97.29% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 93.09% | 95.17% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 92.28% | 96.03% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 92.11% | 97.64% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 91.91% | 97.43% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 91.82% | 96.28% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 91.72% | 96.67% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 91.41% | 97.50% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 90.84% | 97.64% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 90.82% | 97.47% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 90.32% | 90.08% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 90.23% | 83.10% |
| CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 89.87% | 88.81% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 89.78% | 82.69% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 89.75% | 97.50% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 88.94% | 97.29% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 88.90% | 86.67% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 88.89% | 94.45% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 88.75% | 100.00% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 88.30% | 93.00% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 87.96% | 98.33% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 87.93% | 99.17% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 87.89% | 95.36% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 87.88% | 94.33% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 87.66% | 96.90% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 87.34% | 88.42% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 87.09% | 92.86% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 87.07% | 96.33% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 87.05% | 93.33% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 86.94% | 93.10% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 86.91% | 98.75% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 86.74% | 91.11% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 85.91% | 96.00% |
| CHEMBL3105 | P09874 | Poly [ADP-ribose] polymerase-1 | 85.88% | 93.90% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 85.46% | 95.27% |
| CHEMBL2140 | P48775 | Tryptophan 2,3-dioxygenase | 85.41% | 98.46% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 85.29% | 96.38% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 84.81% | 95.00% |
| CHEMBL3238 | P23786 | Carnitine palmitoyltransferase 2 | 84.34% | 94.05% |
| CHEMBL4801 | P29466 | Caspase-1 | 84.00% | 96.85% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 83.91% | 96.25% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 83.43% | 97.23% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 83.34% | 99.17% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 83.17% | 98.77% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 83.14% | 90.71% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 82.70% | 99.00% |
| CHEMBL2474 | P53582 | Methionine aminopeptidase 1 | 82.68% | 97.09% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 82.60% | 92.80% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.25% | 95.50% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 82.20% | 96.67% |
| CHEMBL3691 | Q13822 | Autotaxin | 82.19% | 96.39% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 81.87% | 89.33% |
| CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 81.75% | 81.29% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 81.65% | 89.50% |
| CHEMBL3234 | P08631 | Tyrosine-protein kinase HCK | 81.53% | 88.89% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 81.50% | 89.63% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 81.06% | 96.11% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 81.02% | 92.50% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 80.86% | 92.88% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 80.49% | 90.17% |
| CHEMBL4015 | P41597 | C-C chemokine receptor type 2 | 80.48% | 98.57% |
| CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 80.46% | 93.04% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 80.27% | 95.89% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 80.09% | 82.38% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 101639441 |
| LOTUS | LTS0246788 |
| wikiData | Q105361559 |